These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8808266)
1. [Epidemiologic study of the actual investigation of chronic excretors of Mycobacterium tuberculosis bacilli]. Tsuchiya T; Kondo A; Sakatani M Kekkaku; 1996 Jan; 71(1):31-6. PubMed ID: 8808266 [TBL] [Abstract][Full Text] [Related]
2. [Analysis of chronic excretors of Mycobacterium bacilli in Aichi Prefecture]. Katou M; Kakihara H Kekkaku; 1992 Apr; 67(4):331-46. PubMed ID: 1602726 [TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
4. [II. multidisciplinary analysis of chronic excretors of Mycobacterium tuberculosis bacilli]. Kondo A; Sakatani M; Tsuchiya T; Ogata H; Fujiwara H; Hara H; Yoneda T; Sato K Kekkaku; 1996 Jan; 71(1):25-9. PubMed ID: 8808265 [TBL] [Abstract][Full Text] [Related]
5. [Epidemiological study on factors affecting the hospitalization period of patients with active tuberculosis]. Fujino T; Fusegawa H; Nishiumi M; Okubo Y; Kakizaki T; Maejima K; Sugimori H Kekkaku; 2008 Aug; 83(8):567-72. PubMed ID: 18800648 [TBL] [Abstract][Full Text] [Related]
7. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature]. Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045 [TBL] [Abstract][Full Text] [Related]
8. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results]. Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579 [TBL] [Abstract][Full Text] [Related]
9. [A clinical study on tuberculosis among young adults in Japan: analysis on patients admitted to national hospitals in Kanto- and Kinki-areas in the year 2000]. Yotsumoto H; Yonemaru M; Suzuki K; Kawabe Y; Sasaki Y; Toyoda E; Yamagishi F; Kudoh K; Kurasawa T; Ito M; Kawashiro T; Sakatani M; Mori M Kekkaku; 2003 Aug; 78(8):525-31. PubMed ID: 14509224 [TBL] [Abstract][Full Text] [Related]
10. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy]. Shigeto E; Murakami I; Yokosaki Y Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329 [TBL] [Abstract][Full Text] [Related]
11. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia. Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297 [TBL] [Abstract][Full Text] [Related]
12. [A study of patient's and doctor's delay in patients with pulmonary tuberculosis discovered by visiting doctors with symptoms in particular on doctor's delay]. Sasaki Y; Yamagishi F; Yagi T; Yamatani H; Kuroda F; Shoda H Kekkaku; 2000 Sep; 75(9):527-32. PubMed ID: 11068369 [TBL] [Abstract][Full Text] [Related]
13. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases]. Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128 [TBL] [Abstract][Full Text] [Related]
14. [From the views of bacteriology--focusing on drug susceptibility test]. Ogata H Kekkaku; 1996 Jan; 71(1):37-41. PubMed ID: 8808267 [TBL] [Abstract][Full Text] [Related]
16. Nationwide study of drug resistance among acid-fast bacilli positive pulmonary tuberculosis cases in Lebanon. Araj GF; Saade M; Itani LY Int J Tuberc Lung Dis; 2006 Jan; 10(1):63-7. PubMed ID: 16466039 [TBL] [Abstract][Full Text] [Related]
17. [A study on drug resistance of newly admitted pulmonary tuberculosis patients with special reference to the resistance to SM, INH, EB and RFP]. Harada Y; Kitahara Y; Ninomiya H; Harada S; Takamoto M; Ishibashi T Kekkaku; 1994 Dec; 69(12):751-7. PubMed ID: 7844931 [TBL] [Abstract][Full Text] [Related]
18. Drug-resistant Mycobacterium tuberculosis in Japan: a nationwide survey, 2002. Tuberculosis Research Committee (Ryoken) Int J Tuberc Lung Dis; 2007 Oct; 11(10):1129-35. PubMed ID: 17945071 [TBL] [Abstract][Full Text] [Related]
19. An alarming rate of drug-resistant tuberculosis at Ngwelezane Hospital in northern KwaZulu Natal, South Africa. Lin J; Sattar AN; Puckree T Int J Tuberc Lung Dis; 2004 May; 8(5):568-73. PubMed ID: 15137532 [TBL] [Abstract][Full Text] [Related]
20. Twenty-year trend of chronic excretors of tubercle bacilli based on the nationwide tuberculosis prevalence surveys in Korea, 1975-1995. Hong YP; Kim SJ; Bai JY; Lew WJ; Lee EG Int J Tuberc Lung Dis; 2000 Oct; 4(10):911-9. PubMed ID: 11055757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]